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Propofol is widely used in the clinic for the induction and maintenance of general anesthesia. As with most general 
anesthetics, however, our understanding of its mechanism of action remains incomplete. Local and general anesthetics 
largely inhibit voltage-gated Na+ channels (Navs) by inducing an apparent stabilization of the inactivated state, associated in 
some instances with pore block. To determine the biophysical and molecular basis of propofol action in Navs, we investigated 
NaChBac and NavMs, two prokaryotic Navs with distinct voltage dependencies and gating kinetics, by whole-cell patch 
clamp electrophysiology in the absence and presence of propofol at clinically relevant concentrations (2–10 µM). In both 
Navs, propofol induced a hyperpolarizing shift of the pre-pulse inactivation curve without any significant effects on recovery 
from inactivation at strongly hyperpolarized voltages, demonstrating that propofol does not stabilize the inactivated 
state. Moreover, there was no evidence of fast or slow pore block by propofol in a non-inactivating NaChBac mutant 
(T220A). Propofol also induced hyperpolarizing shifts of the conductance-voltage relationships with negligible effects on 
the time constants of deactivation at hyperpolarized voltages, indicating that propofol does not stabilize the open state. 
Instead, propofol decreases the time constants of macroscopic activation and inactivation. Adopting a kinetic scheme of 
Nav gating that assumes preferential closed-state recovery from inactivation, a 1.7-fold acceleration of the rate constant 
of activation and a 1.4-fold acceleration of the rate constant of inactivation were sufficient to reproduce experimental 
observations with computer simulations. In addition, molecular dynamics simulations and molecular docking suggest that 
propofol binding involves interactions with gating machinery in the S4–S5 linker and external pore regions. Our findings 
show that propofol is primarily a positive gating modulator of prokaryotic Navs, which ultimately inhibits the channels by 
promoting activation-coupled inactivation.
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Introduction
General anesthetics are used on millions of patients each year and 
yet remain some of the most toxic and poorly understood drugs, 
as the exact mechanisms by which they elicit clinical endpoints 
and adverse effects are not known. Propofol is one of the most 
commonly used intravenous agents for induction of anesthesia 
and is often used for maintenance in certain surgical procedures 
(James and Glen, 1980; Feng et al., 2017). Studies have shown that 
propofol potentiates some eukaryotic and prokaryotic inhibitory 
ligand-gated ion channels and inhibits excitatory ones (Hales 
and Lambert, 1991; Lin et al., 1992; Belelli et al., 1999; Dilger, 
2002; Weng et al., 2010; Zhou et al., 2012). Moreover, high-reso-
lution structural studies and photoaffinity labeling experiments 
have revealed the sites of propofol action in several ligand-gated 
ion channels, including GABAA receptors and GLIC (Nury et al., 
2011; Chiara et al., 2014; Jayakar et al., 2014; Woll et al., 2018). 
The anesthetic effects of propofol are thus likely due in part to 
effects on ionotropic receptors. Current models of general anes-
thetic action, however, suggest that the modulation of multiple 
protein targets, including other ion channels, is responsible for 
the clinical endpoints of anesthesia as well as off-target effects 
(Hemmings et al., 2005; Franks, 2008).
Previous work with isolated rat neurohypophysial nerve ter-
minals demonstrated that propofol and the inhaled anesthetic 
isoflurane depress excitatory neurotransmission by inhibiting 
presynaptic voltage-gated Na+ channels (Navs; Ouyang et al., 
2003). In the nerve terminals, inhibition results from the anes-
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thetic-induced hyperpolarization of voltage-dependent inactiva-
tion, a universal feature of general anesthetics in prokaryotic and 
eukaryotic Navs (Rehberg and Duch, 1999; Ouyang et al., 2009; 
Barber et al., 2014; Covarrubias et al., 2015; Sand et al., 2017). In-
triguingly, pore-blocking local anesthetics, such as lidocaine and 
benzocaine, also induce this hyperpolarizing shift (Strichartz, 
1973; Hille, 1977; Lee et al., 2012a). According to the modulated 
receptor hypothesis, local anesthetics bind in the pore of inacti-
vated Navs with high affinity and stabilize the inactivated state, 
which slows recovery from inactivation and, consequently, hy-
perpolarizes the voltage dependence of inactivation (Hille, 1977). 
It is not known, however, whether propofol also inhibits Navs by 
this mechanism.
To gain biophysical and structural insight into the modula-
tion of Navs by propofol, we investigated NaChBac, from Bacillus 
halodurans (Ren et al., 2001), and NavMs, from Magnetococcus 
marinus (McCusker et al., 2012), two prokaryotic Navs with dis-
tinct kinetics and voltage-dependent properties. Despite some 
differences, prokaryotic Navs exhibit many structural and func-
tional features of their eukaryotic counterparts and have served 
as excellent surrogates for investigations into ion channel selec-
tivity and conductance, gating, and pharmacology (Nurani et 
al., 2008; Payandeh et al., 2011; McCusker et al., 2012; Zhang et 
al., 2012; Ulmschneider et al., 2013; Finol-Urdaneta et al., 2014; 
Catterall, 2015; Ahern et al., 2016; Naylor et al., 2016). In contrast 
to the single polypeptide eukaryotic channels consisting of four 
contiguous, homologous pore-forming domains, prokaryotic 
Navs are a tetrameric assembly of identical subunits, which is ex-
perimentally advantageous for mutational studies. Furthermore, 
although prokaryotic Navs lack the intracellular inactivation do-
main responsible for the fast hinged lid mechanism of inactiva-
tion, they do exhibit slow inactivation (Catterall, 2001; Pavlov et 
al., 2005). This has given us the opportunity to ask fundamental 
questions about the modulation of slow inactivation by propofol, 
which may underlie the universal hyperpolarizing effect of gen-
eral anesthetics on steady-state inactivation in Navs.
Several published studies have used prokaryotic Navs to in-
vestigate mechanisms of local and general anesthetic action. Bio-
physical studies suggest that local anesthetics block NaChBac and 
NavMs and promote entry into the inactivated state (Lee et al., 
2012a), and crystallographic studies have linked these functional 
effects to drug binding sites within the pore domain (Bagnéris et 
al., 2014). Volatile general anesthetics such as isoflurane and sevo-
flurane promote activation and inactivation gating in NaChBac 
(Ouyang et al., 2007; Barber et al., 2014; Sand et al., 2017), but 
open pore block has not been ruled out. Molecular dynamics 
(MD) simulations and 19F-NMR studies have proposed novel vol-
atile anesthetic binding sites, including a subset in the pore do-
main that may overlap with local anesthetic binding sites (Raju et 
al., 2013; Barber et al., 2014; Kinde et al., 2016). The binding sites 
associated with the mechanism of action of propofol in Navs, 
however, have not been explored.
Our results demonstrate that propofol modulates NaChBac 
and NavMs in a similar fashion, despite differences in their ki-
netics and voltage-dependent properties. Results from NavMs 
are particularly significant in that its modulation by general an-
esthetics has not previously been reported and that its full-length 
crystal structure was recently solved (Sula et al., 2017), allowing 
structural interpretation of biophysical results and direct mod-
eling of potential interactions. Here, we show that propofol pri-
marily accelerates voltage-dependent activation and separately 
accelerates slow inactivation to a more modest degree. Recov-
ery from inactivation and deactivation are largely unaffected, 
and furthermore, there is no evidence of open pore block. The 
modulated receptor mechanism of local anesthetics thus fails to 
describe the mechanism of action of propofol on these Navs. In-
stead, propofol inhibits these Navs by promoting activation and, 
subsequently, activation-coupled slow inactivation. Consistent 
with the functional results, MD simulations of NavMs revealed 
two potential propofol binding sites: an extracellular pocket near 
the selectivity filter at the intersubunit interface and an intracel-
lular pocket lined by the S4–S5 linker and S6 helix of neighbor-
ing subunits. To link functional effects with structural elements 
of the ion channels, the companion article by Wang et al. in this 
issue uses 19F-NMR to probe putative propfol binding sites in 
NaChBac. Altogether, this study elucidates the biophysical and 
molecular basis of propofol action on prokaryotic Navs and pro-
vides a sound starting point for future investigation of the mech-
anisms of propofol action on eukaryotic Navs.
Materials and methods
Molecular and cell biology
WT NaChBac cDNA in a modified pTracer-CMV2 expression 
vector was a gift from D. Ren (University of Pennsylvania, 
Philadelphia, PA), and WT NavMs cDNA in a modified pTrac-
er-CMV2 expression vector was a gift from P. DeCaen (North-
western University, Evanston, IL) and D. Clapham (Harvard 
University, Boston, MA). cDNA was amplified in bacterial cul-
ture and purified with the QIA GEN Plasmid Midi kit. To gener-
ate NaChBac T220A, a point mutation was introduced into the 
WT plasmid using the QuikChange site-directed mutagenesis 
method (Agilent).
HEK-293 (NaChBac) or HEK-293T (NavMs) cells were tran-
siently transfected with cDNA using the Lipofectamine 2000 
transfection reagent (Invitrogen) and seeded onto 12-mm cir-
cular glass coverslips 24 h before patch clamp recording. Stan-
dard protocols were followed for growth and maintenance of 
cells in culture.
Electrophysiology
Patch pipettes were pulled from borosilicate capillary glass (LA16; 
Dagan) with a HEKA PIP6 micropipette puller. Before recording, 
patch pipettes were fire polished to a final resistance of 1.5 –2.3 
MΩ. Whole-cell patch clamp recording was performed using 
an Axopatch 200B amplifier (Molecular Devices) and Digidata 
1440A analogue-to-digital converter (Molecular Devices). Series 
resistance was compensated at least 85%. Passive leak current 
and capacitive transients were subtracted online by standard P/4 
protocol (NaChBac) or offline using the passive leak subtraction 
feature in pCLA MP (NavMs). All recordings were low-pass Bes-
sel-filtered at 2 kHz and digitized at 15.4 kHz. Clampex 10 (pCLA MP 
10; Molecular Devices) was used to control voltage protocols and 
for data acquisition.
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For NaChBac recordings, the extracellular bath solution con-
tained (in mM) 140 NaCl, 4 KCl, 1.5 CaCl2, 1.5 MgCl2, 10 HEP ES, 
and 5 D-glucose, pH 7.3, adjusted with NaOH; the intracellular 
pipette solution contained (in mM) 15 NaCl, 80 CsF, 40 CsCl, 10 
EGTA, and 10 HEP ES, pH 7.3, adjusted with CsOH. For NavMs 
recordings, the extracellular bath solution contained (in mM) 
150 NaCl, 1.8 CaCl2, 1 MgCl2, and 10 HEP ES, pH 7.4, adjusted with 
NaOH; the intracellular pipette solution contained (in mM) 30 
NaCl, 110 CsF, 1 KCl, 10 HEP ES, and 5 EGTA, pH 7.4, adjusted with 
CsOH. Propofol stock solution (400 µM in bath solution) was pre-
pared by diluting 2,6-diisopropylphenol (Sigma-Aldrich) in bath 
solution, followed by alternating sonication and vortexing for 4.5 
min. The stock solution was then diluted to working concentra-
tions; all dilutions were prepared and used the same day. Cells 
were continuously perfused with bath solution at room tempera-
ture (22–25°C) during recordings. In all experiments, all control 
recordings were collected first, before any anesthetic exposure. 
After control recordings, propofol was perfused for ∼3 min be-
fore collecting paired anesthetic recordings and continuously 
thereafter. To prevent inaccuracies caused by any membrane 
lipid retention of anesthetic molecules and cumulative effects, 
each experimental cell was only exposed to one concentration of 
anesthetic, and washout data were not used.
Voltage protocols
In NaChBac WT and T220A, voltage-dependent activation was 
assessed with Na+ currents evoked by 500-ms depolarizing steps 
(−100 to +60 mV, ΔV = 10 mV) from a holding potential of −120 
mV. Pre-pulse inactivation was assessed with a two-pulse proto-
col: (1) a 2-s conditioning pulse (−120 mV to −10 mV, ΔV = 10 mV), 
followed immediately by (2) a 50-ms test pulse to +10 mV. The 
holding potential was −120 mV. A two-pulse protocol was also 
used to characterize recovery from inactivation: (1) a 2-s condi-
tioning pulse at −10 mV, followed by (2) a 50-ms test pulse to −10 
mV. The pulses were separated by a variable recovery interval (Δt 
= 10 ms to 12 s) at −120 mV. The rate of inactivation at −55 mV was 
determined with a two-pulse protocol: (1) a conditioning pulse of 
variable duration (Δt = 10 ms to 5 s) at −55 mV, followed by (2) a 
50-ms test pulse to −10 mV. The holding potential was −140 mV. 
Deactivation currents were elicited by 900-ms hyperpolarizing 
steps (−120 to −60 mV, ΔV = 10 mV) after a short 15–20 ms acti-
vating pulse to −10 mV.
In NavMs, voltage-dependent activation was assessed with 
Na+ currents evoked by 200-ms depolarizing steps (−140 to +40 
mV, ΔV = 10 mV) from a holding potential of −180 mV. Pre-pulse 
inactivation was assessed with a two-pulse protocol: (1) a 1-s 
conditioning pulse (−170 mV to −60 mV, ΔV = 10 mV), followed 
immediately by (2) a 50-ms test pulse to −30 mV. Recovery from 
inactivation was also characterized with a two-pulse protocol: (1) 
a 500-ms conditioning pulse at −30 mV, followed by (2) a 50-ms 
test pulse to −30 mV. The pulses were separated by a variable re-
covery interval (Δt = 10 ms to 10 s) at −180 mV.
Data analysis
Clampfit 10 (pCLA MP 10, Molecular Devices), Origin 9.1 (Origin-
Lab), and Excel 2013 (Microsoft) were used to analyze volt-
age-clamp data. All evaluated parameters are reported as mean 
± SEM. The paired samples t test was used to assess differences 
between paired datasets in the absence and presence of propofol. 
P values less than 0.05 are explicitly reported in the figures and 
figure legends, and NS indicates P ≥ 0.05.
Peak chord conductance (G) was calculated using G = I / [V − 
Vrev], where I is the measured peak current, V is the command 
potential, and Vrev is the reversal potential extrapolated from in-
dividual current–voltage curves. The voltage dependence of ac-
tivation (G-V curve) was derived from the best-fit fourth order 
Boltzmann function G(V) = [Gmax / (1 + e (Vs – V)/k)]4 and normal-
ized to Gmax, where Gmax is the maximum peak conductance, Vs is 
the midpoint of activation for a single subunit, V is the command 
potential, and k is the slope factor. The midpoint voltage of acti-
vation was calculated using V1/2 = (Vs + 1.67k), and the effective 
gating charge (z) was calculated uzing z = 25.5/k. Pre-pulse inac-
tivation parameters were determined from the best-fit first order 
Boltzmann function I(V) = Imax / (1 + e (V1/2 – V)/k) and normalized to 
Imax, where Imax is the maximum current amplitude and V1/2 is the 
midpoint voltage of inactivation. Time constants of activation 
and inactivation were derived from the rising and decaying com-
ponents of the Na+ current, respectively, using the best-fit single 
exponential of the form I(t) = (A e −t/τ + C), where A is the ampli-
tude, C is the plateau constant, t is time, and τ is the time constant 
of activation or inactivation. Time constants of deactivation were 
derived from tail current relaxations using the best-fit double ex-
ponential of the form I(t) = (A1 e −t/τ1 + A2 e −t/τ2 + C) as a weighted 
mean of τ1 and τ2, where An is the nth component amplitude and 
τn is the nth component time constant. Time courses of recovery 
from inactivation were determined by plotting fractional recov-
ery from inactivation (Ipeak, pulse 2/Ipeak, pulse 1) against the recovery 
interval (Δt). Time constants of recovery were then derived from 
the time courses of recovery using the best-fit single exponential 
of the form y(t) = [y0 + A (1 – e −t/τ)], where A is the amplitude, t 
is the recovery interval, τ is the time constant of recovery from 
inactivation, and y0 is the y intercept. Time courses of the onset 
inactivation were determined by plotting fractional inactivation 
(Ipeak, pulse 2/Io) versus the conditioning pulse duration (Δt), where 
Io is the maximum peak current amplitude. The inactivation time 
constants were then determined from the time courses of inacti-
vation using the best-fit single exponential of the form y(t) = [y0 
+ A e−t/τ], where A is the amplitude, t is the conditioning pulse 
interval, τ is the inactivation time constant, and y0 is the y offset.
Kinetic modeling
Kinetic modeling was based on the six-state kinetic model of 
NaChBac gating previously proposed by Kuzmenkin et al. (2004), 
which has been used by others to model interactions of sevoflu-
rane and isoflurane with NaChBac (Barber et al., 2014; Sand et al., 
2017). This gating scheme was modified to strictly allow closed-
state recovery from inactivation, as described in Results and in the 
Online supplemental material, to globally simulate all key aspects 
of Nav gating examined experimentally. All kinetic simulations 
were performed in IonChannelLab (Santiago-Castillo et al., 2010). 
The objective of these simulations was to qualitatively account 
for all major voltage-dependent and kinetic features of a stereo-
typical prokaryotic Nav in the absence and presence of propofol. 
These features included the voltage dependencies of activation 
Yang et al. 
Mechanisms of propofol modulation in prokaryotic Navs
Journal of General Physiology
https://doi.org/10.1085/jgp.201711924
1302
and inactivation and the kinetics of activation, inactivation, de-
activation, and recovery from inactivation. To generate modeled 
datasets, simulated currents were evoked in IonChannelLab using 
the experimental voltage protocols and analyzed in the same man-
ner as experimentally observed currents. Rate constants were ad-
justed manually and kinetic parameters evaluated in an iterative 
process. Model parameters were first adjusted to approximate the 
control setting without anesthetic, then appropriately refined to 
develop a model of propofol modulation (Table S1).
MD simulations and molecular docking
To discover potential propofol binding sites in Navs, we used an 
MD protocol, hereafter referred to as MD “flooding simulations.” 
In these flooding simulations, a single ion channel molecule is 
exposed to a large number of ligand molecules, a procedure that 
we have previously implemented to study the binding of the vol-
atile anesthetics isoflurane and sevoflurane to NaChBac (Raju 
et al., 2013; Barber et al., 2014). Highly lipophilic ligands with 
large water/octanol partition coefficients like general anesthetics 
rapidly segregate into the lipid bilayer, resulting in a vanishingly 
small bulk solution concentration. Under these conditions, the 
near absence of anesthetic molecules in the aqueous compart-
ment raises computational challenges, as binding events become 
extremely rare. This is in contrast to physiological conditions 
during the administration of volatile anesthetics, where the 
bulk solution concentration remains nearly constant because of 
the equilibrium between the aqueous phase in the blood stream 
and the gaseous phase in the lung alveoli (Eger et al., 1965). Ac-
cordingly, increasing the number of anesthetic molecules in the 
simulated system ensures that the concentration in the aqueous 
compartment remains within the appropriate range during the 
equilibrium phase of sampling. This approach also increases 
sampling of binding events between the anesthetic molecule and 
the molecular surface of the ion channel. Previous computational 
investigations of NaChBac using this method showed that general 
anesthetics can diffuse in and out of the pore in part because of 
their small size and the presence of fenestrations (Payandeh et 
al., 2011; Raju et al., 2013; Barber et al., 2014) and also identified 
isoflurane binding sites that were later corroborated by 19F-NMR 
saturation transfer difference spectroscopy experiments (Kinde 
et al., 2016). Thus, even a submicrosecond MD simulation is likely 
sufficient to explore all relevant protein cavities in the ion chan-
nel. To this end, we applied this computational method to study 
the interactions between propofol and NavMs, for which a full-
length crystal structure is available, specifically focusing on pu-
tative isoflurane binding sites previously identified in NaChBac 
(Raju et al., 2013; Kinde et al., 2016).
MD flooding simulations were performed on the x-ray crys-
tal structure of NavMs in the open conformation (PDB accession 
no. 5HVX; Sula et al., 2017) in a fully hydrated lipid bilayer using 
NAMD 2.10 (Phillips et al., 2005). The simulation system con-
tained a total of ∼122,000 atoms, which included a NavMs te-
tramer, 434 lipid molecules (POPC), 25,310 water molecules, 236 
ions (Cl− and Na+), and 145 propofol molecules. The ratio of water 
to propofol molecules was 174.5, yielding an initial bulk concen-
tration of 0.32 M. The system was equilibrated through three 
consecutive 2-ns stages, in which position restraints on differ-
ent groups were progressively released. The CHA RMM36 force 
field was used for the phospholipids and CHA RMM27 for the pro-
tein (Lee et al., 2014). Propofol parameters were obtained from 
LeBard et al. (2012). To avoid aggregation of propofol molecules, 
indicative of low solubility, a short-range repulsive potential was 
included between drug molecule pairs, using the collective mod-
ule of NAMD 2.12 (Phillips et al., 2005). Periodic boundary con-
ditions were used, and the electrostatic potential was evaluated 
using the particle mesh Ewald method. The lengths of all bonds 
containing hydrogen were constrained with the SHA KE/RAT TLE 
algorithm. Each system was maintained at a temperature of 
300°K and pressure of 1 atm using the Langevin thermostat and 
barostat methods as implemented in NAMD 2.10. The rRES PA 
(reversible reference system propagator algorithm) multiple 
time step method was used, with a high-frequency time step of 2 
fs and a low frequency time step of 4 fs. A trajectory of ∼230 ns 
was collected for subsequent analysis.
Based on the simulation results, we defined binding regions 
for molecular docking calculations to obtain a set of optimal bind-
ing poses and to further analyze channel–propofol interactions. 
Docking of propofol was performed on the x-ray crystallographic 
structure of NavMs in the open state (PDB accession no. 5HVX; 
Sula et al., 2017). The protein structure and parameters were 
assigned using the Protein Preparation Wizard (Schrödinger; 
Sastry et al., 2013), and protonation states were assigned assum-
ing a pH of 7.0. A minimization step was performed using the 
OPLS3 force field (Jorgensen et al., 1996; Harder et al., 2016); a 
threshold of 0.30 Å was used on the RMSD of the heavy atoms 
to assess convergence. Propofol structures and parameters were 
assigned using LigPrep (Schrödinger). For each binding site, a set 
of top scoring binding poses was then obtained using Glide-SP 
(Schrödinger; Friesner et al., 2006).
Online supplemental material
Fig. S1 provides additional NaChBac WT inactivation gating pa-
rameters and also demonstrates representative curve fitting for 
inactivation kinetics. Fig. S2 provides additional NaChBac WT 
and T220A activation gating parameters. Fig. S3 shows represen-
tative curve fitting for NaChBac WT activation and deactivation 
kinetics. Fig. S4 examines the effects of propofol on the rate of 
NaChBac WT inactivation at −55 mV. Fig. S5 shows representa-
tive curve fitting for NavMs inactivation kinetics and provides 
additional information regarding activation and inactivation gat-
ing parameters. Fig. S6 explores other kinetic schemes to model 
NaChBac gating, and Fig. S7 investigates a scenario of propofol 
modulation that does not include effects on inactivation. Fig. 
S8 is a sequence alignment comparing the S4 to S6 segments of 
NaChBac and NavMs. Table S1 contains the kinetic model pa-
rameters used in IonChannelLab to describe NaChBac gating and 
modulation by propofol.
Results
Modulation of WT NaChBac inactivation properties
In general, anesthetics accelerate macroscopic inactivation in 
Navs, which could be a result of either accelerated entry into the 
inactivated state or slow open channel block. At 2, 5, and 10 µM, 
Yang et al. 
Mechanisms of propofol modulation in prokaryotic Navs
Journal of General Physiology
https://doi.org/10.1085/jgp.201711924
1303
propofol consistently accelerated the decay of macroscopic WT 
NaChBac currents over a wide range of membrane potentials 
(Fig. 1, A and B). This current decay was well described by a single 
exponential function (Fig. S1, B and C). At voltages greater than 
−40 mV, where the time constant of inactivation demonstrated 
little to no voltage dependence, propofol exposure decreased the 
time constants uniformly (Fig. 1 B). At +20 mV, for instance, the 
time constant of inactivation was reduced 24 ± 3.9%, 22 ± 5.5%, 
and 33 ± 2.5% at 2, 5, and 10 µM, respectively.
Anesthetics also generally induce parallel hyperpolarizing 
shifts of the pre-pulse inactivation curves in Navs (Covarrubias 
et al., 2015), which points to a relative stabilization of the inac-
tivated state. In WT NaChBac, we observed significant hyperpo-
larizing shifts of the pre-pulse inactivation curves without any 
changes in the corresponding effective gating charge of inacti-
vation (Figs. 1 D and S1 A). At 2, 5, and 10 µM, the changes in the 
midpoint voltage (V1/2) of inactivation compared with control 
were −9.33 ± 0.67, −7.02 ± 1.29, and −11.51 ± 0.65 mV, respectively 
(Table 1). These shifts corresponded to a 25%, 29%, and 32% re-
duction in channel availability in the presence of 2, 5, and 10 µM 
propofol, respectively, at the corresponding baseline midpoint 
voltage (Fig. 1 D).
Figure 1. Modulation of NaChBac inactivation gating by propofol. (A) Representative paired current families in the absence (control) and presence of 
10 µM propofol. Paired scaled INa currents at 0 mV (top) and the voltage protocol (bottom) are shown to the right. (B) Time constants (τ) of inactivation versus 
voltage. Propofol reduced τInactivation at 2, 5, and 10 µM (n = 15–19) at all voltages (9.78E-10 < P < 0.015), with the exception of the 10 µM data point at −40 mV (P 
= 0.059). (C) Pre-pulse inactivation voltage protocol. (D) Pre-pulse inactivation curves of control and with propofol at 2, 5, and 10 µM (n = 7–11). Corresponding 
paired midpoint voltages (V1/2) of inactivation are shown below. Means are indicated in magenta. Error bars indicate ±SEM.
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To test whether these shifts were a result of an actual stabili-
zation of the inactivated state, we examined recovery from inac-
tivation at −120 mV, a strongly hyperpolarized voltage that allows 
isolated investigation of the recovery process. At the same con-
centrations, propofol had no significant effect on the kinetics of 
recovery from inactivation (Fig. 2), which were all well described 
by a single exponential function. At 10 µM, the time constant of 
recovery was 1,075 ± 208 ms, compared with 849 ± 125 ms for 
paired controls (P = 0.2433). Overall, these results demonstrate 
that modulation of NaChBac inactivation by propofol does not in-
volve stabilization of the inactivated state; they do not, however, 
eliminate the possibility of open pore block.
A non-inactivating NaChBac mutant demonstrates no evidence 
of pore block by propofol
Slow open channel blockers of voltage-gated ion channels in-
duce time-dependent decay of the current, which reflects the 
time course of pore block (Armstrong, 1966, 1971; Shin et al., 
2001; Wang et al., 2004; Barber et al., 2014; Sand et al., 2017). 
In NaChBac, however, interpretation of changes in this decay 
could be confounded by the presence of intrinsic inactivation. 
Thus, to directly determine whether propofol acts as a slow open 
channel blocker of NaChBac, we generated NaChBac T220A, a 
previously reported mutant that lacks macroscopic inactivation 
at baseline (Lee et al., 2012a). Examination of this non-inac-
tivating mutant would allow direct observation of any pore 
blocking kinetics in the absence of confounding inactivation. 
Contrary to these expectations, however, there was no evidence 
of slow pore block, as 5 µM propofol failed to induce any current 
decay (Fig. 3 A). Moreover, there was a 16 ± 7.4% increase in the 
maximum peak current amplitude (P = 0.00614; Figs. 3 B and 
S2 B), demonstrating that propofol does not act as a fast resting 
state pore blocker either. These results point to gating modu-
lation as the basis for the acceleration of macroscopic current 
decay induced by propofol in WT NaChBac (Fig. 1 A, inset; and 
Fig. 1 B) rather than open pore block. Consistent with this con-
clusion and the hyperpolarizing shift of the pre-pulse inactiva-
tion curve, propofol also accelerated entry into the inactivated 
state (Figs. 1 and S4).
Modulation of NaChBac activation properties
In Navs, inactivation is inherently coupled to channel activation 
(Armstrong and Bezanilla, 1977; Armstrong, 1981, 2006; Aldrich 
and Stevens, 1987), and thus, effects on activation alone could 
account for changes seen in the voltage dependence and kinetics 
of inactivation. To evaluate the modulation of activation gating 
by propofol, we compared the conductance–voltage (G-V) rela-
tionships of WT and non-inactivating T220A NaChBac in the 
absence and presence of propofol. In both channels, propofol 
induced parallel hyperpolarizing shifts of the G-V curves at all 
concentrations (Fig. 4). In WT NaChBac, the changes in the V1/2 
of activation compared with control were −12.62 ± 0.93, −9.82 
± 1.82, and −14.16 ± 0.93 mV at 2, 5, and 10  µM propofol, re-
spectively (Fig. 4 A and Table 1). At baseline, NaChBac T220A 
demonstrates voltage-dependent activation that is more hyper-
polarized compared with WT (Figs. 4 B and S3 B, left), which 
results from the elimination of inactivation. Nonetheless, 5 µM 
propofol similarly induced a parallel hyperpolarizing shift in 
the G-V curve, corresponding to a change in the V1/2 of acti-
vation of −14.16 ± 0.93 mV, an effect that is also evident in the 
current-voltage (I-V) relationships (Fig. 3 B). This demonstrates 
that positive modulation of activation by propofol in NaChBac 
occurs in a manner that does not depend on the presence of in-
activation and suggests that the propofol-induced acceleration 
of inactivation could result largely from promoting voltage-de-
pendent activation and pore opening.
To investigate the kinetic basis of this positive modulation, we 
determined the time constants of deactivation from tail current 
relaxations and the time constants of activation from the rising 
phase of the inward Na+ currents (Figs. 5 and S4). As is typical for 
voltage-gated ion channels, deactivation dominates at hyperpo-
larized voltages and activation dominates at depolarized voltages, 
with the measured time constants meeting near the V1/2 of activa-
tion. At 2 and 5 µM, propofol failed to induce changes in the time 
constants of deactivation in WT NaChBac and required a high 
concentration (10 µM) to produce observable slowing (Fig. 5 A, 
bottom; and Fig. 5 C). In contrast, all concentrations of propo-
fol reduced the time constants of activation (Fig. 5 A, top; and 
Fig. 5 C). Very similar effects were seen in NaChBac T220A (Fig. 5, 
B and D). These results demonstrate that the propofol-induced 
hyperpolarizing shift of the G-V curve is governed primarily by 
the acceleration of activation gating.
Modulation of NavMs activation and inactivation 
properties by propofol
Results in NaChBac show that propofol does not act via open 
pore block and has favorable effects on both voltage-dependent 
activation and inactivation gating. We next asked whether the 
effects are conserved in NavMs, a prokaryotic Nav for which a 
full-length crystal structure was recently determined (Sula et 
al., 2017). Compared with NaChBac, NavMs displays gating ki-
netics one order of magnitude faster and has a more hyperpo-
larized voltage dependence (Ulmschneider et al., 2013). NavMs 
also exhibits high selectivity for Na+ (Ulmschneider et al., 2013; 
Table 1. Effect of propofol on NaChBac and NavMs gating parameters
NaChBac WT NaChBac T220A NavMs
2 µM 5 µM 10 µM 5 µM 5 µM
ΔV1/2 of activation (mV) −12.62 ± 0.93 −9.82 ± 1.82 −14.98 ± 1.17 −14.16 ± 0.93 −12.46 ± 1.55
ΔV1/2 of inactivation (mV) −9.33 ± 0.67 −7.02 ± 1.29 −11.51 ± 0.65 N/A −13.54 ± 1.61
Changes in the midpoints (V1/2) of activation and inactivation are evident at all concentrations and in all channels tested, P < 0.001, by paired samples t test.
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Naylor et al., 2016) and contains a common binding site for Nav 
antagonists in the central pore (Bagnéris et al., 2014; Buyan et al., 
2018). Despite any functional and structural differences, how-
ever, 5 µM propofol modulated NavMs gating parameters in a 
manner largely mirroring its effects on NaChBac. These effects 
include accelerated Na+ current decay (Fig. 6, A and C; and Fig. S5, 
A and B), parallel hyperpolarizing shifts of both the G-V and pre-
pulse inactivation curves (Fig. 6, D and E; and Fig. S5 C), and no 
effect on recovery from inactivation (Fig. 6 F). Thus, modulation 
by propofol is conserved in both NaChBac and NavMs, suggesting 
that fundamentally similar interactions govern these effects and 
indicating that NavMs provides a robust system for future struc-
tural investigations into general anesthetic action.
Kinetic modeling of prokaryotic Nav gating requires closed-
state recovery from inactivation
We next used computer simulations based on a kinetic model of 
NaChBac gating previously proposed by Kuzmenkin et al. (2004) 
to develop a model of propofol action on prokaryotic Navs. This 
kinetic model of NaChBac gating assumes a sequential six-state 
gating scheme, with channels making voltage-dependent tran-
sitions between the closed and open states and the open and in-
activated states (Fig. S6 A). Importantly, it assumes that channel 
inactivation is strictly coupled to pore opening and that inacti-
vated channels must recover from inactivation via the open state. 
Although the linear model largely reproduces the major features 
of NaChBac gating, it does not adequately model recovery from 
inactivation at −120 mV, yielding a time constant of recovery 
close to experimental values (∼800 ms) but also a time course 
of recovery from inactivation with a considerable y offset (Fig. 
S6 C). This y offset indicates significant channel reopening from 
the inactivated state and produces simulated current families 
that exhibit substantial sustained currents that are not observed 
experimentally (Fig. S6 B, top). Slowing the rate constant of re-
covery from inactivation (β2) by an order of magnitude was able 
to minimize the sustained current (Fig. S6 B, middle) but was 
unable to reproduce the experimentally observed time course of 
recovery from inactivation (Fig. S6 C).
To resolve these discrepancies, we introduced an alternative 
pathway of recovery from inactivation that does not allow chan-
nel reopening (Fig. 7 A, Control). Instead, inactivated channels 
preferentially return to the resting/closed state from the inacti-
vated state. In other words, they must first close (Io → Ic) before 
they are able to return to the pre-open closed state (Ic → C). 
Recovery coupled to deactivation has previously been proposed 
by Kuo and Bean (1994) to describe Nav recovery from inacti-
vation in hippocampal CA1 neurons. The model proposed here 
demonstrates inactivation pathway hysteresis, whereby sepa-
rate pathways are taken to enter and leave the inactivated state. 
In response to a depolarizing step, the Navs activate, open, and 
enter the inactivated state (C → O → Io), which appears absorb-
ing if the depolarized voltage is held. After hyperpolarization, 
the inactivated Navs close and enter the inactivated-closed 
state (Io → Ic) before returning to the pre-open closed state 
(Ic → C), thereby completing the open-inactivation-recovery 
cycle. A similar model of activation-coupled inactivation has 
been described for K+ channels exhibiting C-type inactivation 
(Tilegenova et al., 2017). The proposed model of Nav gating with 
inactivation pathway hysteresis closely described prokaryotic 
Nav gating kinetics while simultaneously allowing complete 
inactivation and sufficiently fast recovery from inactivation 
(Table S1; Fig. S6 B, bottom; and Fig. S6 C). We also found that 
measurements of the rate of inactivation in NaChBac land 
closely to the trajectory of the inward Na+ current, which re-
Figure 2. Propofol does not affect recovery from inactivation in NaCh-
Bac. (A) Time courses of recovery from inactivation. (B) Paired time con-
stants (τ) of recovery in the absence (control) and presence of 2, 5, and 10 µM 
propofol (n = 6–8). Inset shows the voltage protocol. Means are indicated in 
magenta. Error bars indicate ±SEM.
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flects the time-dependent change in open probability at the 
corresponding voltage, thus unambiguously demonstrating 
that inactivation in NaChBac is strictly coupled to pore opening 
(Fig. S4 B; Fineberg et al., 2012).
Propofol primarily accelerates voltage-dependent activation 
to promote inactivation in prokaryotic Navs
Using the model of Nav gating with inactivation pathway hys-
teresis, we next developed a model of propofol modulation 
based on the experimentally observed results. First, we deter-
mined whether positive modulation of activation alone could be 
sufficient to explain the promotion of inactivation (Fig. S7 A), 
a feasible scenario when inactivation is strictly coupled to pore 
opening. A 1.7-fold acceleration of the forward activation rate 
constant α1 combined with a modest 1.25-fold slowing of the 
backward deactivation rate constant β1 was sufficient to quali-
tatively reproduce propofol-induced hyperpolarizing shifts of 
the G-V (ΔV1/2 Activation = −8.68 mV) and pre-pulse inactivation 
(ΔV1/2 Inactivation = −8.23 mV) curves (Fig. S7, B and C). However, 
under these model conditions, macroscopic inactivation was 
not accelerated compared to control at strongly depolarized 
voltages (Fig. S7 D), whereas propofol uniformly decreased ex-
perimentally derived time constants of inactivation over the 
full range of membrane potentials studied (Fig. 1 B). Thus, to 
globally account for all voltage-dependent and kinetic proper-
ties, it was necessary to assume a 1.4-fold acceleration of the 
forward inactivation rate constant α2 in addition to the changes 
in α1 and β1 above. Model parameters can be found in Table S1. 
These assumptions were sufficient to closely account for all as-
pects of propofol modulation of NaChBac and NavMs inactiva-
tion (Fig. 7) and activation (Fig. 8) gating. The kinetic modeling 
therefore supports the experimental findings that propofol pri-
marily modulates voltage-dependent activation, with separate 
but more modest effects on voltage-dependent inactivation, 
and ultimately inhibits prokaryotic Navs by promoting activa-
tion-coupled inactivation.
Figure 3. Propofol does not act as a pore blocker in a non-inactivating NaChBac mutant. (A) Representative paired current families evoked from NaChBac 
T220A in the absence (control) and presence of 5 µM propofol. (B) Normalized current-voltage (I-V) relationships of control and 5 µM propofol from NaChBac 
T220A. Currents were normalized to the maximum peak current of the paired control for each cell (n = 11). Inset shows the voltage protocol. (C and D) Rep-
resentative paired current families (C) and normalized I-V relationships from NaChBac WT (D; n = 15) are shown to provide a side-by-side comparison. Error 
bars indicate ±SEM.
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Discussion
Despite widespread clinical use, the mechanism of action of the 
intravenous general anesthetic propofol is not completely under-
stood. This study provides mechanistic insight into the biophys-
ical and molecular basis of interactions between propofol and 
two prokaryotic Navs, NaChBac and NavMs. These prokaryotic 
Navs share fundamental properties with eukaryotic Navs and 
thus serve as powerful models to investigate the mechanisms of 
propofol action on Navs. Here, we show that propofol (a) hyper-
polarizes the pre-pulse inactivation curve, (b) accelerates the 
rate of macroscopic inactivation, (c) does not affect recovery 
from inactivation at a strongly hyperpolarized voltage, (d) hy-
perpolarizes the G-V curve in both the presence and absence of 
channel inactivation, (e) does not induce slow or fast open pore 
block, (f) accelerates the rate of macroscopic current activation 
with only minor effects on deactivation, and (g) induces nearly 
identical effects in both NaChBac and NavMs. Using kinetic mod-
eling, we determined that the net inhibitory effect of propofol on 
prokaryotic Navs can be explained by significant catalytic action 
on voltage-dependent activation gating and, separately, modest 
catalytic action on slow voltage-independent inactivation gat-
ing. These two distinct effects together ultimately promote ac-
tivation-coupled inactivation, which, as MD simulations of both 
NavMs and NaChBac suggest, might be a result of interactions 
with the ion channel’s gating apparatus (Wang et al., 2018).
Propofol is a positive gating modulator of prokaryotic Navs 
that promotes activation-coupled inactivation
It has been shown that propofol acts as a positive modulator of 
various ion channels (Jayakar et al., 2013, 2014; Li et al., 2016; 
Ton et al., 2017), which are presumably responsible for both the 
desired endpoints and adverse effects of general anesthesia. 
Propofol depresses brain activity in part through the positive 
modulation of ionotropic GABAA receptors (Orser et al., 1994; 
Belelli et al., 1999; Jurd et al., 2003; Zecharia et al., 2009; Woll 
et al., 2015). Pain and irritation caused by the administration of 
Figure 4. Propofol induces a relative stabilization of the open state in both WT and non-inactivating NaChBac. (A) WT (n = 15–19): Normalized peak 
G-V relationships in the absence (control) and presence of 2, 5, and 10 µM propofol, with corresponding paired V1/2s of activation shown below. (B) T220A (n = 
11): Normalized G-V relationships of control and with 5 µM propofol (left) and corresponding paired V1/2s of activation (right). Means are indicated in magenta. 
Voltage protocols are the same as those in Fig. 3. Error bars indicate ±SEM.
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propofol are likely mediated by activation of TRPA1 channels via 
a binding pocket formed by residues of the S5, S6, and first pore 
helix (Ton et al., 2017), and recent photoaffinity labeling stud-
ies point to sites in the S6 helix that may also contribute to the 
ability of propofol to activate TRPA1 channels (Woll et al., 2017b). 
Moreover, as in TRPA1 channels, sevoflurane and propofol also 
positively modulate voltage-gated K+ channels (Woll et al., 2017a; 
Barber et al., 2012; Liang et al., 2015; Bu et al., 2018).
In our investigations, we discovered that propofol also sen-
sitizes prokaryotic Navs to changes in membrane potential, an 
effect that is evident in both the presence and absence of in-
activation (Fig. 4). Ultimately, however, propofol inhibits these 
Figure 5. Propofol preferentially accelerates macroscopic activation in both WT and non-inactivating NaChBac. (A and B) Representative scaled INa 
currents at −40 mV (top) and deactivation currents at −120 mV (bottom) evoked from WT (A) and T220A (B), in the absence and presence of 10 or 5 µM propo-
fol, respectively. Inset shows the deactivation voltage protocol used for both WT and T220A. INa currents were evoked using the voltage protocols shown in 
Fig. 3 B. (C and D) Time constants (τ) of activation (circles, right side) and deactivation (triangles, left side) versus voltage. Propofol reduced τActivation in WT (n 
= 15–19) and T220A (n = 10) at all concentrations and voltages shown compared with control (2.74E-8 < P < 0.035), with the exception of T220A at +40 mV (P 
= 0.10). In WT (n = 5–6), 2 and 5 µM propofol did not increase τDeactivation, except for 2 µM at −60 mV (P = 3.40E-4); 10 µM increased τDeactivation at all voltages 
shown (5.47E-4 < P < 0.015). In T220A (n = 6), 5 µM propofol increased τDeactivation (4.30E-4 < P < 0.035), with the exception of −110 and −70 mV (P = 0.10 and 
0.093, respectively). Error bars indicate ±SEM. In most cases, error bars are smaller than symbols.
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Navs (Fig.  1 D) because inactivation is strictly coupled to acti-
vation and pore opening. In the presence of open-state inacti-
vation, therefore, entry into the inactivated state is governed 
by the voltage-dependent open probability (Fineberg et al., 
Figure 6. Modulation of gating by propofol is conserved in NavMs. (A) Representative paired current families evoked from NavMs in the absence (control) 
and presence of 5 µM propofol. Inset shows representative paired scaled INa currents at 0 mV. (B) Voltage protocols for voltage-dependent activation (top) and 
pre-pulse inactivation (bottom). (C) Time constants (τ) of inactivation versus voltage (n = 20). 5 µM propofol reduced τInactivation at all voltages shown (3.66E-9 < 
P < 0.002). (D and E) Normalized peak G-V relationships (D; n = 20) and normalized pre-pulse inactivation curves (E; n = 12) of control and with 5 µM propofol. 
Corresponding paired V1/2s of activation and inactivation are shown below. Means are indicated in magenta. (F) Time course of recovery from inactivation in 
the absence and presence of 5 µM propofol (left). Corresponding paired time constants (τ) of recovery from inactivation (top), τControl = 1170 ± 109 ms, τ5 µM = 
1436 ± 136 ms (n = 8), and the voltage protocol (bottom) are shown to the right. Error bars indicate ±SEM.
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2012). Consistent with this premise, kinetic modeling demon-
strated that the primary effect of propofol is to promote activa-
tion by accelerating the forward voltage-dependent activation 
rate constant (Figs. 7, 8, and S7). This effect alone accounts for 
the propofol-induced hyperpolarizing shifts of the G-V and 
pre-pulse inactivation curves. Promotion of activation alone 
does not, however, account for the uniform acceleration of the 
time constants of inactivation (Figs. 1 B and S6 D), strongly 
arguing in favor of a multimodal effect. Nonetheless, it is the 
hyperpolarized pre-pulse inactivation curve that ultimately 
dictates inhibition of the inward Na+ current by reducing chan-
nel availability.
Shared features between propofol and local anesthetics
Previous studies have suggested that propofol might act as a 
pore blocker that stabilizes the inactivated state of Navs, much 
Figure 7. Kinetic modeling of NaChBac inactivation properties. (A) Proposed kinetic scheme in the absence (control) and presence of propofol. Model 
parameters are given in Table S1. (B–E) IonChannelLab simulation results of the proposed kinetic schemes. Simulated current families in the absence and 
presence of propofol (B). Inset shows scaled currents at +20 mV. Time constants (τ) of inactivation versus voltage of control and with propofol (C). Pre-pulse 
inactivation curves (D) and recovery from inactivation time courses (E) in the absence and presence of propofol.
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like local anesthetics (Haeseler et al., 2001; Ouyang et al., 2003; 
Stoetzer et al., 2016). However, the reported effects, namely hy-
perpolarization of the steady-state inactivation curve, reduction 
of peak current amplitude, and slowed recovery from inactiva-
tion, could all be attributed to more favorable voltage-dependent 
activation. This possibility arises from the inherent coupling of 
inactivation to voltage-dependent activation, a shared property 
of many voltage-gated ion channels. As a consequence, if volt-
age-dependent activation is hyperpolarized, steady-state inacti-
vation is necessarily hyperpolarized. Thus, within the range of 
voltages over which the Nav undergoes steady-state inactivation, 
the peak current amplitude is reduced, and recovery from inacti-
vation is slowed. Although this pattern of changes might at first 
glance resemble local anesthetic-induced stabilization of the in-
activated state, our data provide a viable alternative explanation.
At strongly hyperpolarized voltages, propofol does not slow 
recovery from inactivation and negligibly slows deactivation in 
NaChBac. Propofol therefore does not stabilize the inactivated or 
open states. Moreover, in the absence of channel inactivation, 
neither instantaneous peak current amplitude reduction nor 
blocking kinetics was observed, which is inconsistent with a 
mechanism involving fast resting state or slow open pore block, 
respectively (Lee et al., 2012a; Goldschen-Ohm and Chanda, 
2014). Hence, propofol does not act on prokaryotic Navs via 
classical local anesthetic mechanisms, namely the guarded and 
modulated receptor hypotheses (Strichartz, 1973; Hille, 1977; 
Goldschen-Ohm and Chanda, 2014). Nonetheless, propofol, the 
local anesthetics lidocaine and benzocaine, and the lidocaine 
derivative ranolazine all accelerate current decay and induce 
hyperpolarizing shifts of the G-V and pre-pulse inactivation 
curves in WT NaChBac (Figs. 1 and 4; Lee et al., 2012a,b). Resem-
bling the mechanisms of propofol action proposed here, Lee et 
al. (2012b) suggested that local anesthetics may promote entry 
into the inactivated state. Like propofol, lidocaine also does not 
affect recovery from inactivation in NaChBac. Notably, however, 
propofol and lidocaine differ in that lidocaine induces robust 
fast resting state block of the non-inactivating T220A NaChBac 
mutant (Lee et al., 2012a) whereas propofol does not (Figs. 3 A 
and S3 B). The dissociation of pore blocking action from effects 
on voltage-dependent gating is consistent with a multisite and 
multimodal hypothesis of anesthetic action. Although propofol 
and local anesthetics appear to diverge with regard to pore block-
ing mechanisms, they may share overlapping allosteric sites near 
and in the pore that are associated with effects on gating.
Shared features between propofol and halogenated 
volatile anesthetics
Despite significant differences in chemical structure, the effects 
of halogenated volatile anesthetics on NaChBac share many 
features with those of propofol and local anesthetics. Ouyang 
et al. (2007) first investigated the modulation of NaChBac by 
isoflurane and proposed a mechanism of inhibition resembling 
that of local anesthetics. Their results appeared consistent with 
state-dependent interactions: stabilization of the inactivated 
state and open pore block (see above). We previously reported 
that sevoflurane also inhibits NaChBac via a mechanism that 
combines favorable voltage-dependent activation and inacti-
vation gating with open pore block (Barber et al., 2014). Inter-
estingly, sevoflurane modestly destabilizes the inactivated state 
by accelerating recovery from inactivation. More recently, Sand 
et al. (2017) revisited the modulation of NaChBac by isoflurane, 
using kinetic modeling to propose a mechanism of inhibition by 
isoflurane that involves increased forward activation and inac-
tivation rate constants. Our results with propofol led to a similar 
conclusion in NaChBac and NavMs, which is further supported 
by semiquantitative global kinetic simulations based on an ex-
tended state model that includes inactivation pathway hystere-
sis (Figs. 7 A and S6). Our experiments additionally exclude the 
presence of fast or slow open pore block and demonstrate that 
Figure 8. Kinetic modeling of NaChBac activation properties. Model 
parameters are the same as in Fig. 7 and are given in Table S1. (A) Peak G-V 
relationships in the absence (control) and presence of propofol. (B and C) Sim-
ulated, scaled activation currents at −40 mV (B) and deactivation tail currents 
at −120 mV (C) of control and with propofol. (D) Time constants of activation 
(circles, right side) and deactivation (triangles, left side) versus voltage, in the 
absence and presence of propofol.
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propofol has negligible effects on recovery from inactivation and 
deactivation kinetics.
Collectively, the similarities between the actions of local and 
general anesthetics on prokaryotic Navs suggest that these ion 
channels feature multiple structural pathways and binding 
pockets that allow promiscuous but functionally important in-
teractions with a group of diverse chemical compounds that gen-
erally share significant hydrophobic character. It is particularly 
interesting that anesthetics also often have sensitizing effects on 
gating through catalytic action or stabilization of activated/open 
states in other related tetrameric ion channels, including K+ and 
TRPA channels (Woll et al., 2017a, 2017b; Arcisio-Miranda et al., 
2010; Barber et al., 2012; Liang et al., 2015; Ton et al., 2017). This 
observation points to the possibility of shared and/or related 
binding sites in other ion channels as well.
Potential propofol binding sites and modulatory 
mechanisms in NavMs
Definitively linking functional observations to a discrete set of 
well-defined binding sites would require extensive investigation 
and validation that are beyond the scope of the present study. 
However, some qualitative conclusions can be drawn based on 
available information, specifically regarding the binding of iso-
flurane to NaChBac (Raju et al., 2013). Given the many shared 
features of NaChBac’s functional response to both isoflurane and 
propofol (Sand et al., 2017) and the strikingly similar responses 
of NaChBac and NavMs to propofol, these general anesthetics 
could share binding sites in prokaryotic Navs. Although largely 
speculative, this hypothesis is consistent with many indepen-
dent observations of distinct general anesthetics across many 
ion channels of the 6TM family, as discussed previously.
To this end, we performed MD flooding simulations on 
NavMs (see Materials and methods) and assessed the locations 
of two putative isoflurane binding sites previously identified in 
NaChBac (Raju et al., 2013) for potential propofol binding: an ex-
tracellular pocket near the selectivity filter at the intersubunit 
interface and an intracellular pocket lined by the S4–S5 linker 
and S6 helix of neighboring subunits (Fig. 9 A). Monitoring the 
distances between propofol molecules and the side chains lining 
these binding sites during the simulation showed that there is 
steric complementarity between the propofol molecule and both 
binding sites and that binding at each of these locations occurs 
within a few tens of nanoseconds (Fig. 9 F). Although this does 
not allow us to draw conclusions about occupancy of these sites 
under physiological conditions, it shows that binding is possible. 
We then performed molecular docking to conduct a more detailed 
analysis of the propofol-NavMs interactions at these locations 
and identified the side chains in NavMs that are most likely to be 
in contact with propofol (Fig. 9, C and E).
At the S4–S5 linker, the propofol molecule fits snugly in a 
pocket that is almost perfectly complementary in shape to the 
anesthetic molecule (Fig. 9 D). Binding in this pocket seems to be 
dominated by nonpolar interactions; the side chains lining the 
binding pocket are all hydrophobic in character except for T225. 
The propyl and phenyl moieties of propofol establish extensive 
interactions with the side chains of V131, V134, N212, and M222 
(Fig. 9 E), and in several binding poses, the propofol hydroxyl 
group is positioned to form a hydrogen bond with the main 
chain carbonyl of G130. As the S4–S5 linker is critical for elec-
tromechanical coupling and channel gating (Long et al., 2005; 
Payandeh et al., 2011), identification of a potential binding site 
at the S4–S5 linker is consistent with experimental findings that 
propofol acts as a gating modulator of prokaryotic Navs. Propofol 
binding on the extracellular side of the pore domain occurred 
near the selectivity filter at the interface between adjacent sub-
units (Fig. 9 B). Here, the propofol molecule established extensive 
contacts with R186 and N190 as well as K166 of the adjacent sub-
unit (Fig. 9 C). Propofol might also interact with the outer pore 
region to modulate the equilibrium between conductive and 
non-conductive conformations of the selectivity filter, which 
has been implicated in slow inactivation in both eukaryotic Navs 
and in NaChBac (Xiong et al., 2003; Pavlov et al., 2005). Iden-
tification of these two potential binding sites lends additional 
support to a multisite and multimodal hypothesis of propofol ac-
tion. In the companion article, Wang et al. (2018) characterized 
propofol binding at the S4–S5 linker and at a number of other 
candidate binding sites using 19F-NMR. Further investigation will 
be required to validate the functional relevance of these sites to 
propofol action in Navs.
Although it is not possible to definitively link the binding 
pocket formed by the S4–S5 linker and S6 segment to the modu-
lation of activation and inactivation gating based on the results 
presented here, it is very likely that interactions at this location 
are involved, given that these regions are highly conserved in 
both NaChBac and NavMs (Fig. S8) and given their shared func-
tional modulation by propofol. This hypothesis is also strongly 
supported by previous work investigating the action of volatile 
general anesthetics on structurally related ion channels, such as 
NaChBac, Kv, and TRP channels (Woll et al., 2017a, 2017b; Barber 
et al., 2012, 2014; Zhang et al., 2013; Liang et al., 2015; Kinde et al., 
2016; Ton et al., 2017; Bu et al., 2018). Toward linking our findings 
to mechanisms of general anesthetic action in eukaryotic Navs, 
this binding pocket near the S4–S5 linker is especially intriguing 
in light of the recent cryo-EM structure of Nav1.4 from electric 
eel Electrophorus electricus (EeNav1.4) in complex with the β1 
subunit (Yan et al., 2017). In the structure, the III-IV cytoplasmic 
linker containing the LFM fast inactivation motif is found wedged 
into the corner enclosed by the S4–S5 linkers and S6 of domains 
III and IV, precisely the location of the putative propofol binding 
pocket in NavMs. If the III-IV cytoplasmic linker mediates fast 
inactivation through an allosteric mechanism that induces pore 
closure, propofol may mimic the inactivation gate when it binds 
to this pocket, thereby promoting entry into the inactivated state.
Limitations of the model system and kinetic modeling
It is uncertain whether the mechanism of propofol action on 
NaChBac and NavMs proposed here can be completely extrap-
olated to eukaryotic Navs. Several experimental observations, 
however, are consistent with fundamental aspects of anesthetic 
mechanisms: (1) local and general anesthetics universally hy-
perpolarize the voltage dependence of inactivation gating in 
Navs (Hille, 1977; Bean et al., 1983; Ouyang et al., 2003, 2007, 
2009; OuYang and Hemmings, 2007; Lee et al., 2012a; Barber 
et al., 2014; Sand et al., 2017), (2) local anesthetics are able to 
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modulate voltage sensor conformations of eukaryotic Navs 
(Sheets and Hanck, 2003, 2007; Muroi and Chanda, 2009), and 
(3) Na+ channel blockers inhibit NavMs and hNav1.1 with com-
parable potencies and at similar binding sites (Bagnéris et al., 
2014). It is conceivable that these similarities are determined 
by shared fundamental structural features that underlie slow 
inactivation in the pore domain as discussed above. Despite 
these observations, major structural features only found in eu-
karyotic Navs, such as their pseudotetrameric architecture and 
the III-IV cytoplasmic linker responsible for fast inactivation 
(Vassilev et al., 1988; West et al., 1992; Catterall, 2012), could 
alter the ways in which anesthetics antagonize Nav function. 
These differences could explain why anesthetics do not stabi-
lize the inactivated state of prokaryotic Navs (Fig. 2; Lee et al., 
2012a,b; Barber et al., 2014; Sand et al., 2017) and why general 
anesthetics do not inhibit prokaryotic Navs by fast or slow open 
channel block (Fig. 3). Propofol might inhibit eukaryotic Navs 
through a combination of mechanisms that includes both the 
modulation of activation gating and slow inactivation that is 
conserved in prokaryotic Navs and local anesthetic-like mod-
Figure 9. MD simulations and molecular docking in NavMs. (A) Side view of potential propofol binding sites in NavMs identified by MD simulations. 
Alternating subunits are shown in dark/light blue. (B and D) Zoomed-in surface views of the extracellular (B) and S4–S5 linker binding sites (D). (C and E) 
The top six propofol binding poses at the extracellular binding site (C) and top 10 propofol binding poses at the S4–S5 linker binding site (E), from molecular 
docking simulations. (F) Time courses of the minimum distance between the bound propofol molecule and the residues lining the two binding sites, from MD 
simulations. For both sites, propofol binding occurred in three of the four subunits, denoted as Linker 1–3 and Extracellular 1–3; distances are not reported for 
the unoccupied subunit. Residues lining the S4–S5 linker site (left) consisted of V134, N212, and A221, and those lining the extracellular site (right) consisted 
of R186, M189, and K166.
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ulation of fast inactivation gating with open pore block that is 
exclusive to eukaryotic Navs.
Ideally, quantitative global kinetic modeling examining 
multiple aspects of gating over a wide range of voltages would 
provide the most stringent test for possible mechanisms 
(Dougherty et al., 2008; Kaulin et al., 2008). This was unfor-
tunately not experimentally feasible in this study because of 
limitations in patch stability, which prevented application of 
all voltage protocols to the same cell in the absence and pres-
ence of propofol. Nonetheless, we were able to produce robust 
datasets suitable for semiquantitative kinetic modeling, which 
served as a framework to formulate a plausible mechanism of 
action. These datasets yielded comprehensive experimental 
information on the various aspects of voltage-dependent gat-
ing (activation, deactivation, inactivation, and recovery from 
inactivation) over a wide range of voltages (−170 to +60 mV). 
Moreover, we performed these experiments at three relevant 
concentrations of propofol and repeated a critical subset of 
these experiments in both NaChBac and NavMs. Notably, the 
observed effects demonstrated little concentration dependence, 
which indicates that the concentrations of propofol tested may 
have been saturating. This is consistent with in vivo observa-
tions in tadpoles (Hall et al., 2010). We cannot, however, dismiss 
the possibility that cell-to-cell variability obscured concentra-
tion dependence, but in any case, the consistency of the results 
strengthens the conclusions.
Conclusion
Mounting evidence points to voltage-gated Na+ channels as im-
portant general anesthetic targets (Herold and Hemmings, 2012), 
but understanding the molecular mechanisms of this modulation 
is the first step toward identifying relevant anesthetic binding 
regions in Navs. We have found that propofol inhibits NaChBac 
and NavMs by promoting activation-coupled inactivation, which 
may involve multiple binding sites within the channel. Further 
investigation with mutational analysis will be required to assess 
the contributions of individual putative binding sites to the ef-
fects of propofol on these Navs. Moving forward, recent advances 
in photoaffinity labeling techniques and the availability of the 
full-length crystal structure for NavMs will permit in-depth 
structural investigations to help validate the significance of these 
sites in the mechanism of propofol action.
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